2012-10-10 21:25:51 - New Pharmaceuticals market report from Global Markets Direct: "Herpes Simplex Infections - Pipeline Review, H2 2012"

Global Markets Direct's, 'Herpes Simplex Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Herpes Simplex Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections. Herpes Simplex Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of

data for the indicated disease.


Full Report Details at
- www.fastmr.com/prod/468445_herpes_simplex_infections_pipeline_re ..


Scope

* A snapshot of the global therapeutic scenario for Herpes Simplex Infections.
* A review of the Herpes Simplex Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Herpes Simplex Infections pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Herpes Simplex Infections.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Herpes Simplex Infections pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Herpes Simplex Infections Overview
Therapeutics Development
An Overview of Pipeline Products for Herpes Simplex Infections
Herpes Simplex Infections Therapeutics under Development by Companies
Herpes Simplex Infections Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Herpes Simplex Infections Therapeutics - Products under Development by Companies
Herpes Simplex Infections Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Herpes Simplex Infections Therapeutics Development
Vical Incorporated
Antigenics, Inc.
GenVec, Inc.
Novartis AG
CEL-SCI Corporation
Mymetics Corporation
NanoViricides, Inc.
Nutra Pharma Corporation
Peregrine Pharmaceuticals, Inc.
CytoGenix, Inc.
Alnylam Pharmaceuticals, Inc
Flamel Technologies S.A.
Starpharma Holdings Limited
Summit Corporation plc
BioAlliance Pharma SA
Oryzon
Functional Genetics, Inc.
Colby Pharmaceutical Company
Osel Inc.
AiCuris GmbH & Co. KG
Asahi Kasei Pharma
AlphaVax, Inc.
Nitric Biotherapeutics, Inc.
Romark Laboratories, L.C.
Chimerix, Inc.
Lumavita AG
NanoBio Corporation
PharmaNova Inc.
Immune Design Inc.
Redox Pharmaceutical Corporation
PepTcell Limited
Genocea Biosciences, Inc.
Beech Tree Labs, Inc.
EMS S.A.
Herpes Simplex Infections - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
tenofovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
acyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RPI-78M - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RPI-MN - Drug Profile
Product Description
Mechanism of Action
R&D Progress
famciclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
simplivir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CEL-1000 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
doxorubicin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HSV Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NB-001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LMV-601 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HSV-2 Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HSV-2 Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HerpV Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AIC-316 - Drug Profile
Product Description

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468445&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.